Biosite beats Street

BSTE reported second quarter diluted EPS of $0.76, beating by $0.09 the Street's $0.67 consensus estimate and up 29% from $0.59 in the second quarter of 2004. Product sales came in at $71.9 million, up 22% from $58.8 million in the same period last year. Sales of the company's Triage BNP test for heart failure rose 21% to $49.1 million from $40.4 million a year ago. ...